| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 9 |
| 1 | INFLIXIMAB | 8 |
| 2 | PREDNISONE | 8 |
| 3 | METHOTREXATE SODIUM | 7 |
| 4 | BEVACIZUMAB | 6 |
| 5 | METHOTREXATE | 6 |
| 6 | PANCRELIPASE | 6 |
| 7 | SITAGLIPTIN | 5 |
| 8 | ACETAMINOPHEN | 4 |
| 9 | AZATHIOPRINE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BROMOCRIPTINE MESYLATE | 1 | 0.0015 |
| 1 | CALCIUM POLYCARBOPHIL | 1 | 0.0003 |
| 2 | BARICITINIB | 1 | 0.0003 |
| 3 | BELANTAMAB MAFODOTIN | 1 | 0.0003 |
| 4 | MITOXANTRONE HYDROCHLORIDE | 2 | 0.0003 |
| 5 | ENCORAFENIB | 2 | 0.0002 |
| 6 | REGORAFENIB | 2 | 0.0002 |
| 7 | PANCRELIPASE | 6 | 0.0002 |
| 8 | CEFDINIR | 1 | 0.0001 |
| 9 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 1 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 2 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 3 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 6 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 7 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |